Department of Psychological and Brain Sciences, Washington University in St Louis, St Louis, Missouri.
Department of Psychiatry, Washington University in St Louis School of Medicine, St Louis, Missouri.
JAMA Psychiatry. 2021 Jan 1;78(1):64-76. doi: 10.1001/jamapsychiatry.2020.2902.
In light of increasing cannabis use among pregnant women, the US Surgeon General recently issued an advisory against the use of marijuana during pregnancy.
To evaluate whether cannabis use during pregnancy is associated with adverse outcomes among offspring.
DESIGN, SETTING, AND PARTICIPANTS: In this cross-sectional study, data were obtained from the baseline session of the ongoing longitudinal Adolescent Brain and Cognitive Development Study, which recruited 11 875 children aged 9 to 11 years, as well as a parent or caregiver, from 22 sites across the United States between June 1, 2016, and October 15, 2018.
Prenatal cannabis exposure prior to and after maternal knowledge of pregnancy.
Symptoms of psychopathology in children (ie, psychotic-like experiences [PLEs] and internalizing, externalizing, attention, thought, and social problems), cognition, sleep, birth weight, gestational age at birth, body mass index, and brain structure (ie, total intracranial volume, white matter volume, and gray matter volume). Covariates included familial (eg, income and familial psychopathology), pregnancy (eg, prenatal exposure to alcohol and tobacco), and child (eg, substance use) variables.
Among 11 489 children (5997 boys [52.2%]; mean [SD] age, 9.9 [0.6] years) with nonmissing prenatal cannabis exposure data, 655 (5.7%) were exposed to cannabis prenatally. Relative to no exposure, cannabis exposure only before (413 [3.6%]) and after (242 [2.1%]) maternal knowledge of pregnancy were associated with greater offspring psychopathology characteristics (ie, PLEs and internalizing, externalizing, attention, thought and, social problems), sleep problems, and body mass index, as well as lower cognition and gray matter volume (all |β| > 0.02; all false discovery rate [FDR]-corrected P < .03). Only exposure after knowledge of pregnancy was associated with lower birth weight as well as total intracranial volume and white matter volumes relative to no exposure and exposure only before knowledge (all |β| > 0.02; all FDR-corrected P < .04). When including potentially confounding covariates, exposure after maternal knowledge of pregnancy remained associated with greater PLEs and externalizing, attention, thought, and social problems (all β > 0.02; FDR-corrected P < .02). Exposure only prior to maternal knowledge of pregnancy did not differ from no exposure on any outcomes when considering potentially confounding variables (all |β| < 0.02; FDR-corrected P > .70).
This study suggests that prenatal cannabis exposure and its correlated factors are associated with greater risk for psychopathology during middle childhood. Cannabis use during pregnancy should be discouraged.
鉴于孕妇中大麻使用量的增加,美国外科医生最近发布了一项关于怀孕期间使用大麻的建议。
评估怀孕期间大麻的使用是否与后代的不良结局有关。
设计、地点和参与者:在这项横断面研究中,数据来自正在进行的纵向青少年大脑与认知发展研究的基线会议,该研究于 2016 年 6 月 1 日至 2018 年 10 月 15 日从美国 22 个地点招募了 11875 名 9 至 11 岁的儿童及其父母或照顾者。
母亲知道怀孕前后的产前大麻暴露情况。
儿童的精神病理学症状(即类精神病体验[PLE]和内化、外化、注意力、思维和社会问题)、认知、睡眠、出生体重、出生时的胎龄、体重指数和大脑结构(即总颅内体积、白质体积和灰质体积)。协变量包括家族(如收入和家族精神病理学)、妊娠(如产前接触酒精和烟草)和儿童(如物质使用)变量。
在 11489 名儿童(5997 名男孩[52.2%];平均[SD]年龄,9.9[0.6]岁)中,有非缺失的产前大麻暴露数据,655 名(5.7%)儿童产前接触大麻。与无暴露相比,母亲知道怀孕前后仅暴露于大麻(413[3.6%])和仅在母亲知道怀孕后暴露于大麻(242[2.1%])与更大的后代精神病理学特征(即 PLE 和内化、外化、注意力、思维和社会问题)、睡眠问题和体重指数相关,认知和灰质体积也较低(所有|β|>0.02;所有假发现率[FDR]校正 P<.03)。仅在母亲知道怀孕后暴露于大麻与出生体重以及总颅内体积和白质体积低于无暴露和仅在母亲知道怀孕前暴露于大麻有关(所有|β|>0.02;所有 FDR 校正 P<.04)。当纳入潜在混杂因素时,母亲知道怀孕后暴露于大麻仍与更大的 PLE 和外化、注意力、思维和社会问题相关(所有β>0.02;FDR 校正 P<.02)。仅在母亲知道怀孕前暴露于大麻与无暴露相比,在考虑潜在混杂变量时,在任何结果上均无差异(所有|β|<0.02;FDR 校正 P>.70)。
这项研究表明,产前大麻暴露及其相关因素与儿童中期精神病理学风险增加有关。应劝阻孕妇使用大麻。